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Abstract
Camels are increasingly becoming the livestock of choice for pastoralists reeling from
effects of climate change in semi-arid and arid parts of Kenya. As the population of camels
rises, better understanding of their role in the epidemiology of zoonotic diseases in Kenya is
a public health priority. Rift Valley fever (RVF), brucellosis and Q fever are three of the top
priority diseases in the country but the involvement of camels in the transmission dynamics
of these diseases is poorly understood. We analyzed 120 camel serum samples from north-
ern Kenya to establish seropositivity rates of the three pathogens and to characterize the
infecting Brucella species using molecular assays. We found seropositivity of 24.2% (95%
confidence interval [CI]: 16.5–31.8%) for Brucella, 20.8% (95% CI: 13.6–28.1%) and 14.2%
(95% CI: 7.9–20.4%) for Coxiella burnetii and Rift valley fever virus respectively. We found
27.5% (95% CI: 19.5–35.5%) of the animals were seropositive for at least one pathogen and
13.3% (95% CI: 7.2–19.4%) were seropositive for at least two pathogens. B. melitensis was
the only Brucella spp. detected. The high sero-positivity rates are indicative of the endemic-
ity of these pathogens among camel populations and the possible role the species has in
the epidemiology of zoonotic diseases. Considering the strong association between human
infection and contact with livestock for most zoonotic infections in Kenya, there is immediate
need to conduct further research to determine the role of camels in transmission of these
zoonoses to other livestock species and humans. This information will be useful for design-
ing more effective surveillance systems and intervention measures.
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Author summary
Dromedary camels are well adapted to the arid and semi-arid environment that makes up
about 80% of Kenya’s landmass. As such, camels play an important role in the socio-eco-
nomic wellbeing and food security of pastoralists in the country. However, the species
remains relatively neglected in scientific research, one of the main reasons being camels
are mostly found in remote, low-income, arid regions of Africa and Asia. We carried out a
study to determine the levels of exposure of camels in northern Kenya to Brucella spp.,
Coxiella burnetii and Rift Valley fever virus, three priority zoonotic pathogens in the coun-
try. We found high levels of exposure to the three pathogens, indicating the important
role camels might play in the epidemiology of the zoonotic diseases in humans and other
livestock. Based on the study findings, we argue for the immediate need for investments
in disease surveillance and control strategies for priority zoonotic disease in camels in
Kenya.
Introduction
The emergence of the Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012
and the subsequent detection of the virus in dromedary camels, brought into focus the role of
the species as potential reservoirs of endemic and emerging zoonotic diseases in Kenya [1–4].
As the population of camels and their contribution to food security and economy of pastoral-
ists in the country continues to rise, understanding this role is a public health priority [5–7].
The burden and transmission dynamics of zoonotic diseases in Kenyan camels are poorly
understood. This has led to the perception of low burden of camel diseases, the consequence of
which is continued neglect of the camel industry in resource allocation for disease control and
research [8, 9].
Previous studies have identified camels as reservoirs of three of the top priority zoonotic
pathogens in Kenya; Brucella spp, Rift Valley fever virus (RVFv) and Coxiella burnetii, but data
on infection patterns of these pathogens, and potential co-infections in camels is limited [2, 8,
10]. Serological studies, however, show that camels have high seroprevalences and may play an
important role in the epidemiology of the three pathogens [2, 11]. Camels have been reported
to have the highest Brucella and Coxiella burnetii infection rates among Kenyan livestock, with
one study reporting more than a two-fold increase in Brucella prevalence in livestock herds
with camels versus those with none [8, 12, 13]. Similarly, camels play an important but under-
appreciated role in the epidemiology of RVFV, one of the pathogens with the highest exposure
levels in Kenyan camels [8]. In addition to the high prevalence rates, high camel mortality
rates during RVF outbreaks in Kenya and the association of camels with confirmed human
RVF cases are indicative of role of camels in the epidemiology of the virus [14–16].
Co-exposure with multiple pathogens has been shown to alter host-pathogen interactions
(within and between host pathogen dynamics) which in turn may affect clinical consequences,
transmission dynamics and response to prevention and control measures [17–19]. Whereas,
advances in diagnostic techniques have increased interest in understanding pathogen interac-
tions, most epidemiological studies in livestock focus on single-pathogen exposures despite the
fact that most zoonotic diseases present with similar clinical symptoms and have the same risk
factors [20].
Although presence of antibodies for a given pathogen indicates exposure and not necessary
active infections, it is an integral component of disease risk assessment. In this study, we inves-
tigated the seroprevalences of RVFV, Brucella spp and Coxiella burnetii and characterized
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This study did not require ethical approvals from an institutional review board because it was
conducted as part of an outbreak investigation by the Kenya Ministry of Agriculture, Livestock
and Fisheries and Ministry of Health. However, full approval for the study was given by the
Director of Veterinary services in Kenya and local county-level Directors of Veterinary Ser-
vices in the study area. Although individual informed consent was not required for this investi-
gation, all data were handled as a de-identified set to protect farmers’ privacy and
confidentiality.
Study area
We utilized 120 camel sera samples collected from 16 herds during an outbreak investigation
of a respiratory syndrome of unknown aetiology in dromedary camels between 22nd and 28th
June 2020. Sera samples were collected from herds with history of at-least one camel present-
ing with a respiratory syndrome in the 3 months preceding the investigation. The investigation
was conducted in Isiolo and Samburu counties, both of which are semi-arid, pastoral regions
of northern Kenya (Fig 1). In Isiolo, sampling was conducted in Kinna and Burat wards, while
in Samburu camel samples were collected from Wamba West and Nyiro wards. Pastoralism,
characterized by transhumance movement is the predominant livestock production system in
both study areas. Cattle, goats, sheep and camels are the main species kept in the study area,
but goats and sheep form the bulk of livestock in the two counties. Isiolo and Samburu are also
home to several wildlife conservancies with significant population of free roaming wildlife and
human-animal-wildlife interaction.
Sample collection
Ten millimeters of blood was collected into plain vacutainer tubes from each animal through
jugular venipuncture. Serum was then extracted through centrifugation at the laboratories
located within county veterinary offices. After serum separation, samples were transferred into
2mls cryovials, labeled and transported in a motorized cool box at 4oc to the International
Livestock research Institute, Nairobi for laboratory analysis and testing. Study data was col-
lected electronically in Epi-Info (CDC Atlanta, Georgia, USA). Standardized and pre-tested
questionnaires were uploaded to smart phones and administered to key informants; primarily
camel owners and herders, to collect data on herd and animal level information such as age
and sex.
Laboratory procedure
All serum samples were tested in duplicates for Brucella, RVFV and Coxiella burnetii antibod-
ies using ID screen Brucellosis Serum Indirect ELISA Multispecies kits (IDvet innovative diag-
nostics, France), ID screen Rift Valley Fever Competition Multispecies ELISA kits (IDvet
innovative diagnostics, France) and Q fever (Coxiella burnetii) Antibody test kit (IDEXX Labo-
ratories, Westbrook ME, USA) respectively. Samples that tested positive for Brucella on ELISA
test were further subjected to two PCR assays to detect the genus Brucella and a speciation
assay to identify Brucella species. All the testing was done according to manufacturer standard
operating procedures.
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Based on the manufacturer’s instruction, the results were interpreted as negative if the cal-
culated S/P% was<30%, positive if the S/P was�40% and doubtful if the S/P was in between
30 and 40%.
Real time PCR detection of Brucella spp.
DNA extraction from serum samples. Total DNA was extracted from all the 32 Brucella
sero-positive samples using QIAamp DNA Blood Mini Kit, while following the manufacturer’s
instructions. Briefly, 20 μl of proteinase K solution, 200μl of the serum sample and lysis buffer
were added into a sterile 1.5ml Eppendorf tube, vortexed and incubated at 56˚C for 10 min-
utes. Absolute ethanol (200μl) was then added into the mixture and vortexed before applying
the lysate onto a QIAamp spin column. The columns were centrifuged at 8000 rpm for one
minute followed by a two wash steps using 500μl for each buffer AW1 and AW2 respectively.
Centrifugation with buffer AW1 was done at 8000 rpm for 1 minute while AW2 was done at
maximum speed for 3 minutes. The DNA was eluted from the spin column using buffer 70μl
AE and centrifugation at 8000 rpm for one minute. Eluted DNA was spectrophotometrically
Fig 1. Map of the study area showing the sampled wards (in orange). Shape file used from: https://africaopendata.org/dataset/kenya-counties/shapefile/resource/
0b78f25e-494e-4258-96b8-a3ab2b35b121.
https://doi.org/10.1371/journal.pntd.0009275.g001
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checked for quality and quantified using NanoDrop 1000 UV-Vis spectrophotometer (Thermo
Scientific, Waltham, MA, USA) and stored at -20˚C until when required for analysis.
Real-time PCR. Real-time PCR targeting IS711 gene was done to detect the genus Bru-
cella in the extracted DNA samples using oligonucleotide primers and probes (S1 Table). The
samples were considered PCR-positive for Brucella if they had a genus-specific amplification
with a thresh hold value (<40) in one or all the duplicate samples. The genus PCR-positive
samples were subsequently subjected to a multiplex speciation assay with B. abortus, B. meli-
tensis and B. suis species-specific oligonucleotide primers and probes. For both genus and spe-
cies-specific PCR assays, the test samples were considered positive when they had an
amplification with cycle threshold (Ct) values <40 for either or both duplicates (S1 Text).
Statistical analysis. Field and laboratory data were stored in Microsoft Excel files. They
were imported to R statistical computing environment [21] for descriptive and statistical anal-
ysis. Variables that were available for analysis included (i) three dependent variables that repre-
sented exposure states of the three pathogens: RVFV, Brucella spp. and Coxiella burnetii,
recorded as either positive or negative, and two independent factors—age and sex of an ani-
mal. Herd and animal identification numbers were used for merging the data.
Seroprevalence for each of the three pathogens and their 95% confidence intervals were
estimated using binom.confint function. An asymptotic method of estimating these intervals
was specified for all the tests. Chi-square or Fisher’s exact test (where values were less than 10)
were used to assess the significance of statistical associations between independent variables—
age and sex and the dependent variables. Additional dependent variables that represented co-
occurrence of two or all the target pathogens were also generated and used in similar analyses
[22].
Univariable mixed-effect logistic regression models were fitted to data with age and sex
being used as predictors in turns. Variables that were statistically significant (P<0.05) in the
univariable analyses were then used in mixed effects logistic regression model that had herd as
a random effect. Where age and sex were present and significant, their interaction terms were
included and tested for their significance using likelihood ratio tests. The Akaike’s Information
Criterion (AIC) was used to analyze the goodness of fit of the model. The data is presented in
tables and plots. We used a sjstats package to generate Intracluster Correlation Coefficient
(ICC), which measures the degree of correlation of prevalence estimates within herds after
running the mixed effects model [23]. Intracluster correlation coefficient is a measure of vari-
ability of infection between herds.
Results
We analyzed 120 samples collected from 16 camel herds with no history of vaccination against
brucellosis, Coxiella and RVFV. Majority of the camel samples were from females (72%,
n = 86) and camels aged above five years (49%, n = 49) as shown in Table 1.
Table 1. Age and sex distribution of sampled camels.
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Brucella had the highest seropositivity rate of the three pathogens at 24.2% (95% confidence
interval [CI]: 16.5–31.8%), followed by Coxiella burnetii at 20.8% (95% CI: 13.6–28.1%) and
RVFV at 14.2% (95% CI: 7.9–20.4%). Co-exposure to two or more pathogens was detected in
15.0% (95% CI: 8.6–21.4%; n = 18) of the samples. Up to 27.5% (95% CI: 19.5–35.5%) of the
animals were seropositive for at least one pathogen and 13.3% (95% CI: 7.2–19.4%) were sero-
positive for at least two pathogens. Of those with co-exposures, 92% (n = 22) had 2 co-expo-
sures detected, the rest of the samples (n = 2) had antibodies to all three pathogens. Co-
exposure with Brucella species for both RVFV and Coxiella burnetii were the most common
detections. On multivariate analysis, age was found to be significantly associated with co-expo-
sure to Brucella and Coxiella as shown in Table 2.
Identification of Brucella species in camels
Thirty-two Brucella (including three borderline positive samples not included in calculation of
seropositivity) sero-positive samples were run through PCR for DNA detection. Half of these
samples were positive for Brucella on PCR (n = 16). Of these, five samples (32%) were positive
for Brucella melitensis. Eleven of 16 samples positive for Brucella genus on PCR could not be
confirmed by the Brucella species PCR.
Discussion
The historical neglect of camels and the perception of the species as hardy and resistant to dis-
eases has contributed to limited understanding of their role in the epidemiology of zoonotic
pathogens relative to other livestock [8, 24, 25]. Filling this knowledge gap in Kenya; a country
with one of the largest camel population globally, is not only key in the economic development
and growth of the camel industry, but in reducing the burden of zoonotic diseases in the coun-
try [5].
Brucellosis is one of the most important, yet understudied zoonoses in Kenya [26–28]. Our
study found more than one in every five camels had been exposed to Brucella spps., which con-
forms to reported camel brucellosis prevalence range (of up-to 40%) in the East Africa region
[26, 29]. Studies conducted in areas of Kenya with similar agro-ecological characteristics and
Table 2. Final multivariable mixed effect model of association between select factors with exposure to one or more pathogens with random effects for herd ID.
Variable and category Targeted pathogens and their levels of co-exposure among sampled animals
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0.77 0.019 0.03 <0.001 14.68 0.005 73.03 0.032 1.67 0.002 5.96 0.034
The intra-herd correlation
coefficient (ICC) for herd ID
0.19 0.01 0.82 0.96 0.26 0.64
https://doi.org/10.1371/journal.pntd.0009275.t002
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animal husbandry practices in 2012 and 2014, found positivity rates of 11% (ELISA) and
6–18% (serum agglutination test) respectively [30, 31]. The high camel brucellosis prevalence
rates in northern Kenya are indicative of the high risk of human infection and interspecies
transmission [9, 32]. In literature, camels are reported to be susceptible to B. melitensis and B.
abortus [33–35]. In our study however, we only detected B. melitensis after testing for B. abor-
tus, B.suis and B. melitensis. The detection of only B. melitensis is in agreement with similar
reports in literature that surmise that B. melitensis is more prevalent in African and Middle
East camels than B. abortus [26, 36]. A plausible explanation is that camels are generally herded
together with goats as opposed to cattle because of better adaptation of the former to harsher
climates; primarily less water requirement, ability to walk longer distances and well adapted
dietary preferences [36, 37]. However, our finding should not be deduced to mean that B. meli-
tensis does not affect Kenyan camels, but rather the need for comprehensive studies on the
molecular epidemiology of brucellosis in Kenyan camels [26, 38].
Data on the burden of Q fever in northern Kenyan camels is scarce [8, 39]. However, stud-
ies in camels in Central Kenya found high Coxiella burnetii positivity rates of between 18.6% -
46%, which is in the range of our 21% prevalence finding [12, 13, 40]. The high Coxiella preva-
lence in camels is a source of public health concern because of the strong association between
Coxiella camel positivity and human infection [41, 42]. Additionally, the high exposure rates
indicate camels might play an important role as reservoirs of Coxiella in mixed livestock herds
[42–44].
Outbreaks of Rift valley fever have been frequently reported in Kenya since the first detec-
tion of the virus in 1931[45, 46]. Traditionally, cattle, sheep and goats are considered to be the
species of interest during RVF outbreaks but emerging evidence shows camels play a signifi-
cant epidemiological role during epizootics [14, 47, 48]. Our study found a positivity rate of
14% which is lower than previously reported rates of 57% and 21% from two studies conducted
in 2007 [15, 48]. Other studies in the region have found varying infection rates from 9.6% in
Sudan and 45% in Tanzania [49, 50]. The differences in infection rates can be attributed to dif-
ferences in agro-climatic zones, one of the drivers of RVF infection and different sampling
periods; epidemic versus interepidemic period [51, 52]. Our study found a strong association
between Brucella and Coxiella co-exposure exposure and camels above five years. This can be
explained by the increased likelihood of exposure to the two pathogens over time due to their
endemicity [14, 53]. Intra-herd correlation coefficient values are key in calculating sample
sizes for multistage sampling [54]. The ICC for RVFv infection was the highest of the three
pathogens. This can be inferred to mean RVFv infection within a camel herd is highly corre-
lated. This can be explained by the fact that RVF is a vector borne disease that occurs in explo-
sive outbreaks in very specific ecologies, meaning camels in such areas have much higher
exposure rates than those that are not [55]. The persistence of RVFv antibodies in camels com-
pared to the two other pathogens, a hypothesis supported by the fact that age was significantly
associated with RVFv exposure in our study, is also a plausible explanation for the high ICC
estimate within herds. ICC is an important variable in the calculation of a design effect, a cor-
rection factor applied to sample sizes to correct for errors inherent from using cluster sam-
pling, however information on ICCs for most livestock diseases in developing countries are
unknown. Given our ICC estimates for exposures and co-exposures with RVFv were higher
than the 0.2 value assumed for most infectious diseases, there is need for further investigation
and to reconsider the outcome for estimation of ICC in camels [56–58].
Co-exposure with multiple pathogens is a common phenomenon in nature [19]. This is
especially true for livestock in pastoral communities in Sub-Saharan Africa with no structured
disease control programs, a consequence of which is continuous exposure to endemic patho-
gens [18, 59]. Extrinsic (environmental) and intrinsic (host-specific) factors influence burden
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and consequence of co-infections, but these are poorly understood for most endemic livestock
diseases in sub-Saharan Africa [59, 60]. Although the outcomes of in vivo pathogen interac-
tions are poorly understood, it is known co-infections can result in change in severity of infec-
tion, alteration of transmission dynamics and variation in physiologic response which can
change effectiveness of diagnostic techniques, control and prevention efforts [18, 53, 61, 62].
Studies on the outcomes of co-infection in livestock provide evidence of antagonistic effects of
co-infection on the host. An example is the Th1 and Th2 immunity response to Toxoplasma
gondii and nematode infection or in Trypanomosa cruzi and helminth infections where the
former activates Th1 immune response pathways and the latter the Th2 pathways [20, 63]. The
three pathogens of interest in the study can affect the immune system; Brucella species and
Coxiella burnetii can infect macrophages while RVFv is can affect monocytes [55, 64–67]. Live-
stock reared under pastoral production system are highly vulnerable to co-exposure to patho-
gens due to high population densities, widespread movement and frequent contact from
sharing pasture and watering points [42, 68]. Our study evaluated co-exposures with the three
pathogens in camels as a start to understanding burden of mixed infection and possible out-
comes. This is important because zoonotic spillover pathways and clinical presentation of the
three infections are very similar and understanding these co-exposures can inform surveillance
strategies and integrated disease control and prevention plans in the long term.
Conclusion
This study provides evidence of high exposure rates to the three priority zoonotic pathogens in
camels in northern Kenya. Considering the increasing value of camels in food nutrition for
pastoralists in Kenya, there is need for more research investment to understand the role of
camels in the epidemiology of these diseases. Because the endemicity of these diseases is
already established, further research should focus on robust studies to estimate the incidence,
transmission between livestock species and from animals to humans, and maintenance hosts
for these zoonotic infections to guide future control and elimination programs.
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